Clinical trial Recruiting at 1 site Interventional Ages 18 to 43

Using antioxidant-rich media to improve embryo quality in IVF

Official title: Antioxidants-enriched Single-step vs Global Total Single-step Embryo Culture Media: Effect on Blastocyst Euploidy Rates.

Run by ART Fertility Clinics LLC · NCT06261671 · Data updated 2026-11-12

This study is testing if using a special culture solution with antioxidants can help improve the quality of embryos for people undergoing IVF.

Quick facts

Study typeInterventional
Ages18 Years to 43 Years
SexAll
Enrollment500 (estimated)
SponsorART Fertility Clinics LLC
Academic / other
Locations1 site (Abu Dhabi, Abu Dhabi Emirate)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedFebruary 21, 2025
Trial IDNCT06261671 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18-43 undergoing IVF with sufficient oocytes for intracytoplasmic sperm injection (ICSI).

Probably not a fit

Patients undergoing preimplantation genetic testing for monogenic disorders (PGT-M) or those using testicular sperm will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effect of antioxidant-enriched culture media on the euploidy rates of embryos during in vitro fertilization (IVF). It aims to address the negative impact of reactive oxidative species (ROS) on embryo development by utilizing a culture medium that contains higher concentrations of antioxidants. The trial will involve a randomized approach using sibling oocytes from patients undergoing assisted reproductive technology cycles. The primary goal is to determine if this improved culture condition can enhance the quality of embryos suitable for implantation.

Why it matters

Potential benefit: If successful, this approach could lead to higher rates of viable embryos and improved outcomes for patients undergoing IVF.

How similar studies have gone: While few human IVF studies have explored this approach, animal models have shown promising results, indicating potential for success in human applications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing assisted reproductive technology cycles when ICSI is indicated.
* Patients when Iin vitto fertilization (IVF) is also performed will be included as far as there are enough oocytes for ICSI randomization. However, IVF oocytes will not be used for the study.
* Maternal age 18-43 years old.
* PGT-A cycles with only trophectoderm biopsies on day 5/6/7.
* Patients with more than 6 COCs expected for ICSI.
* Body mass index \<35.
* Fresh and frozen ejaculated sperm.

Exclusion Criteria:

* PGT-M cycles
* Fresh and frozen testicular sperm.

Where it's running

  • ART Fertility Clinics LLC
    Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.